Literature DB >> 29450575

Osteoblastomatosis: an unusual diagnosis and treatment.

Elena Quílez-Caballero1, José Martel-Villagran2, Ángel Luis Bueno-Horcajadas2, Laura López-Brasal2, María Jesús Díaz-Candamio3.   

Abstract

Osteoblastomatosis (OBLT), also referred to as multifocal osteoblastoma (OB), is an unusual and recently described entity consisting of multifocal tumors histologically consistent with osteoblastoma and osteoid osteoma (OO) but radiologically mimicking a vascular bone lesion. OBLT treatment is based on aggressive procedures, such as amputation, en bloc resection, and chemotherapy. Only one previously reported case was successfully treated following a multimodal approach consisting of curettage, cryotherapy, intravenous bisphosphonates, and radiofrequency ablation. We present a case of OBLT that may have been cured by CT-guided percutaneous radiofrequency ablation.

Entities:  

Keywords:  Bone; CT; Computed tomography; Osteoblastoma; Osteoblastoma-like; Osteoblastomatosis; Osteoid osteoma; Radiofrequency ablation

Mesh:

Year:  2018        PMID: 29450575     DOI: 10.1007/s00256-018-2891-y

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  13 in total

1.  Osteoblastomatosis of bone. A benign, multifocal osteoblastic lesion, distinct from osteoid osteoma and osteoblastoma, radiologically simulating a vascular tumor.

Authors:  Michael Kyriakos; Georges Y El-Khoury; Douglas J McDonald; Joseph A Buckwalter; Murali Sundaram; Barry DeYoung; Michael P O'Brien
Journal:  Skeletal Radiol       Date:  2006-04-25       Impact factor: 2.199

2.  Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity.

Authors:  Costantino Errani; Lei Zhang; David M Panicek; John H Healey; Cristina R Antonescu
Journal:  Clin Orthop Relat Res       Date:  2011-09-24       Impact factor: 4.176

3.  A unique multifocal osteoblastoma-like tumor of the bones of a single lower extremity. Report of a case.

Authors:  J X O'Connell; D I Rosenthal; H J Mankin; G K Gudger; G R Dickersin; A L Schiller; A E Rosenberg
Journal:  J Bone Joint Surg Am       Date:  1993-04       Impact factor: 5.284

4.  CT-guided radiofrequency ablation of spinal osteoblastoma: treatment and long-term follow-up.

Authors:  Francesco Arrigoni; Antonio Barile; Luigi Zugaro; Eva Fascetti; Marcello Zappia; Luca Brunese; Carlo Masciocchi
Journal:  Int J Hyperthermia       Date:  2017-06-09       Impact factor: 3.914

5.  Multimodality treatment of a multifocal osteoblastoma-like tumor of the lower extremity.

Authors:  Jeffrey E Mait; Giorgio Perino; Aasis Unnanuntana; Tai-Li Chang; Stephen Doty; Robert Schneider; Joseph M Lane
Journal:  Skeletal Radiol       Date:  2012-02-13       Impact factor: 2.199

6.  Clinical long-term outcome, technical success, and cost analysis of radiofrequency ablation for the treatment of osteoblastomas and spinal osteoid osteomas in comparison to open surgical resection.

Authors:  Marc-André Weber; Simon David Sprengel; Georg W Omlor; Burkhard Lehner; Bernd Wiedenhöfer; Hans-Ulrich Kauczor; Christoph Rehnitz
Journal:  Skeletal Radiol       Date:  2015-04-25       Impact factor: 2.199

7.  Osteoblastoma: clinical and radiologic findings in 98 new cases.

Authors:  H M Kroon; J Schurmans
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

8.  [Percutaneous radiofrequency ablation of benign bone tumors: osteoid osteoma, osteoblastoma, and chondroblastoma].

Authors:  J Martel Villagrán; A Bueno Horcajadas; E J Ortiz Cruz
Journal:  Radiologia       Date:  2009-10-28

9.  Epithelioid multinodular osteoblastoma: a clinicopathologic analysis of 26 cases.

Authors:  Renée Zon Filippi; Ronald G Swee; K Krishnan Unni
Journal:  Am J Surg Pathol       Date:  2007-08       Impact factor: 6.394

10.  Clinical and morphological characteristics of osteoid osteoma and osteoblastoma: a retrospective single-center analysis of 204 patients.

Authors:  Ulviye Yalcinkaya; Basak Doganavsargil; Murat Sezak; Burcin Kececi; Mehmet Argin; Gulcin Basdemir; Fikri Oztop
Journal:  Ann Diagn Pathol       Date:  2014-08-27       Impact factor: 2.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.